Skip to content

Preparation of sticky mucus gel containing Nigella sativa extract, comparison and evaluation of its clinical effect with Clotrimazole vaginal cream 1% for the treatment of vulvovaginal candidiasis.

Preparation of sticky mucus gel containing Nigella sativa extract, comparison and evaluation of its clinical effect with Clotrimazole vaginal cream 1% for the treatment of vulvovaginal candidiasis.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220510054813N1
Enrollment
102
Registered
2023-03-16
Start date
2023-04-04
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaginal candidiasis. Candidiasis of vulva and vagina

Interventions

Intervention 1: Intervention group: People who receive sticky mucus gel containing black seed extract. Intervention 2: Control group: People who receive clotrimazole 1% cream.

Sponsors

Zanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Presence of clinical symptoms of vulvovaginal candidiasis Insensitivity to Nigella sativa

Exclusion criteria

Exclusion criteria: diseases such as diabetes pregnancy Allergy to nigella sative Cortone use Taking antibiotics in the last two weeks

Design outcomes

Primary

MeasureTime frame
In this study, after filling the written informed consent form, the person is examined. People diagnosed with vulvovaginal candidiasis (Candida albicans); Randomly, one group will be given vaginal gel with sticky black seed and one group will be given Clotrimazole 1% cream in the same package, which patients should use once every night for a week through an applicator. After a week, patients return for re-examination, which is checked for improvement of symptoms and clinical examination. Timepoint: One week after starting treatment. Method of measurement: Examination of clinical symptoms such as secretions, itching, inflammation and odor.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactshabnam Towfighi

Zanjan University of Medical Sciences

shabnam.towfighi@gmail.com+98 21 8806 4148

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026